Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05740098 · ClinicalTrials.gov registry record · NA
Financial Incentives for Smoking Cessation Among Mothers
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 198
- Enrollment target
NCT05740098 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 198 participants.
The verdict
NCT05740098, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 198 participants
- Enrollment target
Study Summary
Investigators will examine whether adding financial incentives and nicotine replacement dual therapy to current best practices for smoking cessation (i.e. referral to counseling using a telephone quit line) increases cessation rates in mothers and reduces second-hand smoke exposure in children. While perhaps more expensive upfront compared to best practices alone, the investigators hypothesize that this treatment approach will be a more cost-effective cessation intervention.
Interventions
- BEHAVIORAL Financial Incentives
- DRUG Nicotine Replacement Therapy
- BEHAVIORAL Best Practices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2015-06 |
| Est. Completion | 2020-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05740098
The ClinicalTrials.gov registry entry for NCT05740098 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Financial Incentives is the first listed.
NCT05740098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05740098 about?
NCT05740098 is a clinical study titled "Financial Incentives for Smoking Cessation Among Mothers". Investigators will examine whether adding financial incentives and nicotine replacement dual therapy to current best practices for smoking cessation (i.e. referral to counseling using a telephone quit line) increases cessation rates in mothers and reduces second-hand smoke exposure in children. Whil...
What is the current status of trial NCT05740098?
This trial is currently completed. It is a NA study. The enrollment target is 198 participants. The study started on 2015-06. Estimated completion is 2020-10.
What interventions are being tested in trial NCT05740098?
The interventions under investigation include: Financial Incentives (BEHAVIORAL), Nicotine Replacement Therapy (DRUG), Best Practices (BEHAVIORAL).
Who is sponsoring clinical trial NCT05740098?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.